Who
Regan J. Lauer
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, ImmunityBio; SVP - Controller, Banc of California.
In numbers
- Trades disclosed
- 87
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $289K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 31 Dec 2005
- Last trade
- 22 Feb 2026
- Last filed
- 24 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —4,065 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $15K1,673 at $8.70 | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —4,065 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —4,065 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —4,065 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $15K1,673 at $8.70 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —5,482 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $16K2,257 at $6.93 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —5,482 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —5,482 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —5,482 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $16K2,257 at $6.93 | filing |
| 22 Feb 2025filed 25 Feb 2025 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —4,065 at $0.00 | filing |
| 22 Feb 2025filed 25 Feb 2025 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —4,065 at $0.00 | filing |
| 22 Feb 2025filed 25 Feb 2025 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $5,7081,669 at $3.42 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —16,447 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —56,250 at $0.00 | filing |
| 15 Dec 2024filed 16 Dec 2024 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —21,031 at $0.00 | filing |
| 15 Dec 2024filed 16 Dec 2024 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code M | —21,031 at $0.00 | filing |
| 15 Dec 2024filed 16 Dec 2024 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code F | $22K7,503 at $2.87 | filing |
News
Banc of California (BANC) Expected to Post Earnings on TuesdayBANC · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Regan J. Lauer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.